Last data update: Jun 24, 2024. (Total: 47078 publications since 2009)
Records 1-1 (of 1 Records) |
Query Trace: Gallagher Kathleen [original query] |
---|
ROSES-S: Statement from the World Health Organization on the reporting of seroepidemiologic studies for SARS-CoV-2
World Health Organization Seroepidemiology Technical Working Group , Hamida Amen Ben , Udhayakumar Venkatachalam , Gallagher Kathleen . Influenza Other Respir Viruses 2021 15 (5) 561-568 Well-designed population-based seroepidemiologic studies can be used to refine estimates of infection severity and transmission, and are therefore an important component of epidemic surveillance. However, the interpretation of the results of seroepidemiologic studies for SARS-CoV-2 has been hampered to date principally by heterogeneity in the quality of the reporting of the results of the study and a lack of standardized methods and reporting. We provide here the ROSES-S: Reporting of Seroepidemiologic studies-SARS-CoV-2. This is an updated checklist of 22 items that should be included in the reporting of all SARS-CoV-2 seroepidemiologic studies, irrespective of study design. |
- Page last reviewed:Feb 1, 2024
- Page last updated:Jun 24, 2024
- Content source:
- Powered by CDC PHGKB Infrastructure